Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

DOI

10.1038/d41586-021-01571-1

Type

Journal article

Journal

Nature

Publication Date

06/2021

Volume

594

Pages

330 - 332

Keywords

Drug discovery, Medical research, Research management, SARS-CoV-2, Animals, Antiviral Agents, COVID-19, Clinical Trials as Topic, Cooperative Behavior, Coronavirus 3C Proteases, Crowdsourcing, Crystallography, X-Ray, Drug Discovery, Drug Evaluation, Preclinical, Drug Repositioning, Goals, Humans, International Cooperation, Israel, Open Access Publishing, SARS-CoV-2, Social Media, Synchrotrons, Time Factors, United Kingdom, Videoconferencing, Volunteers, World Health Organization, COVID-19 Drug Treatment